Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
The new facility is scheduled to start operation in the first half of 2024
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
Aveir VR is specifically designed to be retrieved when therapy needs to evolve or the device needs to be replaced
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
It is currently available in tablet and injectable dosage forms
The two-day event will showcase achievements and address issues pertaining to the industry
Subscribe To Our Newsletter & Stay Updated
